TVARDI THERAPEUTICS, INC.

Profile

Company Names

TVARDI THERAPEUTICS, INC.

Addresses

2450 HOLCOMBE BOULEVARD, SUITE X, HOUSTON, TX 77021

7000 FANNIN STREET, SUITE 1960M, HOUSTON, TX 77030

Phone Numbers

832-413-1362

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$78,067,913.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-06-03 
$72,418,254.00 
$75,058,256.00 
$2,640,002.00 
Equity 
1
2018-06-04 
$5,649,659.00 
$8,500,000.00 
$2,850,341.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
IMRAN 
 
ALIBHAI 
EXECUTIVE OFFICER, DIRECTOR
TVARDI THERAPEUTICS, INC.
RONALD 
 
DEPINHO 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  KARYOPHARM THERAPEUTICS INC.   |  TVARDI THERAPEUTICS, INC.
WALLACE 
 
HALL 
DIRECTOR
VOOKS, INC.   |  TVARDI THERAPEUTICS, INC.
JAMIE 
 
MCNAB 
DIRECTOR
TVARDI THERAPEUTICS, INC.
SUJAL 
 
SHAH 
DIRECTOR
CYMABAY THERAPEUTICS, INC.   |  TVARDI THERAPEUTICS, INC.
DAVID 
J. 
TWEARDY 
EXECUTIVE OFFICER, DIRECTOR
TVARDI THERAPEUTICS, INC.
MICHAEL 
 
WYZGA 
DIRECTOR
ONCOMED PHARMACEUTICALS INC   |  PROSENSA HOLDING N.V.   |  AURA BIOSCIENCES, INC.   |  X4 PHARMACEUTICALS, INC.   |  MEREO BIOPHARMA GROUP PLC   |  TVARDI THERAPEUTICS, INC.   |  X4 PHARMACEUTICALS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-03 
2018-07-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-04 
2018-06-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#